WO2003014106A1 - METHOD FOR PREPARING OPTICALLY ACTIVE α-SUBSTITUTED HETEROCYCLICCARBOXYLIC ACID ESTER - Google Patents

METHOD FOR PREPARING OPTICALLY ACTIVE α-SUBSTITUTED HETEROCYCLICCARBOXYLIC ACID ESTER Download PDF

Info

Publication number
WO2003014106A1
WO2003014106A1 PCT/KR2002/001488 KR0201488W WO03014106A1 WO 2003014106 A1 WO2003014106 A1 WO 2003014106A1 KR 0201488 W KR0201488 W KR 0201488W WO 03014106 A1 WO03014106 A1 WO 03014106A1
Authority
WO
WIPO (PCT)
Prior art keywords
substituted
heterocycliccarboxylic
acid
organic solvent
optically active
Prior art date
Application number
PCT/KR2002/001488
Other languages
French (fr)
Inventor
Ki-Nam Uhm
Original Assignee
Genofocus Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genofocus Co., Ltd. filed Critical Genofocus Co., Ltd.
Publication of WO2003014106A1 publication Critical patent/WO2003014106A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Definitions

  • the present invention relates to a method for preparing an optically active compound, more particularly, relates to a method for preparing an optically active compound from an racemic ⁇ -substituted heterocycliccarboxylic acid ester.
  • Optically active tetrahydro-2-furoic acid a representative compound of optically active ⁇ -substituted heterocycliccarboxyic acids has a wide variety of uses as a chiral building block.
  • R- (+) -tetrahydro-2- furoic acid is useful as a side chain intermediate of penem antibiotics
  • S- (-) -tetrahydro-2-furoic acid is useful as a chiral intermediate of organic synthesis.
  • an optical resolution must be performed. The optical resolution of racemates has been performed first by Belanger in 1983 ⁇ Can . J. Chem. 61:1383(1983)).
  • JP Publication No. 1989-216983 discloses a method for optical resolution of R, S-tetrahydro-2-furoic acid conversed into a diastereomer salt using l-(4- phenylhalide) ethylamine as a resolving agent.
  • the method also has problems such as high expense of optically active amines, very low concentration of R, S-tetrahydro-2- furoic acid and low purity and yield of products.
  • Optical resolutions of racemic amine have been reported, for example, Reetz, M. T. et al . have resolved racemic 2- phenylethylamine using Candida antarctica lipase (CAL) in purity of 99%ee by acylation of .R-isomeric amine ( Chimia . 48:570(1994)). This method has been known to be applicable to optical resolutions of other amines .
  • CAL Candida antarctica lipase
  • racemic compounds that may be optically resolved into chiral compounds by aminolysis using lipase include a wide variety of compounds.
  • a method for preparing an optically active ⁇ -substituted heterocycliccarboxylic acid ester of the formula II and/or an optically active ⁇ -substituted heterocycliccarboxylic acid amide of the formula III which comprises the steps of: (a) dissolving in an organic solvent a racemic compound of ⁇ -substituted heterocycliccarboxylic acid ester represented by the formula I; (b) adding an enzyme selected from the group consisting of lipase, protease and esterase, and R-NH 2 to a solution containing the racemic compound; and (c) isolating the optically active compounds of the formula II and the formula III from the reaction mixture;
  • R x is non-substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl ;
  • R is H or non-substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl;
  • X is 0, S or N; and n is an integer of 1-5.
  • the compound with R or S configuration among racemic ⁇ -substituted heterocycliccarboxylic acid ester as starting material is resolved through aminolysis by an enzyme that interacts only a specific enantiomer and R-NH 2 to form an amide compound, whereas non-reacted compound remains as ester compound.
  • An enantiomer is resolved by the enantiomer- specific reaction.
  • the reaction of this invention is defined as aminolysis used herein, including ammonolysis as well as usual meaning of aminolysis. As described hereinafter, although ammonolysis- occurs when ammonia is used as R-NH 2 , it is also considered to occurrence of aminolysis herein.
  • racemic compound of ⁇ -substituted heterocycliccarboxylic acid ester by the formula I an starting material
  • racemic compound , “racemate” and “racemic mixture” have the same meaning, and each means a mixture of enantiomers deficient in optical activity in which each enantiomer is mixed substantially at a ratio of 50:50.
  • the racemic ⁇ -substituted heterocycliccarboxylic acid may be dissolved in a variety of organic solvents, which include but not limited to oxane, ester, ether, alcohol solvents and mixtures thereof, more preferably is oxane, alcohol organic solvents or combination thereof.
  • organic solvents include but not limited to oxane, ester, ether, alcohol solvents and mixtures thereof, more preferably is oxane, alcohol organic solvents or combination thereof.
  • the preferred oxane organic solvent of this invention includes 1,4-dioxane or 1, 3 , 5-trioxane .
  • the ester organic solvent includes ethylacetate, ethylpropionate, ethylbutyrate, butylbutyrate and butylacetate.
  • the preferred ether organic solvent includes diethylether, methylethylether, methyl tert-butylether, methylisobutylether and petroleum ether.
  • the organic solvent is alcohol.
  • a different reaction from one represented by the Scheme I is produced. That is, transesterification as well as aminolysis occurs simultaneously. Therefore, in another aspect of this invention, there is provided a method for preparing an optically active ⁇ - substituted heterocycliccarboxylic acid ester of the formula II, an optically active ⁇ -substituted heterocycliccarboxylic acid ester of the formula IV and/or an optically active ⁇ -substituted heterocycliccarboxylic acid amide of the formula III, which comprises the steps of: (a) dissolving in an alcoholic organic solvent of R 2 -0H a racemic compound of the ⁇ -substituted heterocycliccarboxylic acid ester of the formula I; (b) adding an enzyme selected from the group consisting of lipase, protease and esterase, and R-NH 2 to a solution containing the racemic compound; and (c
  • R x and R 2 is independently non-substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl;
  • R is H or non- ' substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl;
  • X is O, S or N; and n is an integer of 1-5.
  • one enantiomer is subject to aminolysis by enzymes and R-NH 2 and R 2 -0 " acts on non-reacted another enantiomer to form a new ester compound (formula IV) .
  • racemic ⁇ -substituted heterocycliccarboxylic acid ester is optically resolve by aminolysis in an organic solvent
  • the reaction time is too long, the yield of optically active ⁇ -substituted heterocycliccarboxylic acid ester may be reduced due to overreaction.
  • alcohol organic solvent is used to produce transesterification and aminolysis simultaneously, the optical purity and the yield of final products can be improved and reaction time can be reduced as well.
  • the final products include 2 types of optically active ⁇ -substituted heterocycliccarboxylic acid esters and a ⁇ - substituted heterocycliccarboxylic acid amide having an opposite optical activity.
  • Ri and R 2 is independently non-substituted or substituted C ⁇ -C 6 alkyl, C ⁇ -C 6 alkenyl, C ⁇ -C e alkynyl, C 3 -C 6 cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl;
  • R is H or non- substituted or substituted C ⁇ -C 6 alkyl, C ⁇ -C 6 alkenyl, C ⁇ -C 6 alkynyl, C 3 -C 6 cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl;
  • X is 0; and n is an integer of 1-3.
  • the alcohol organic solvent useful in this invention preferably includes but not limited to methanol, ethanol, isopropanol, n-propanol, n-butanol, isobutanol, tert- butanol, isoamylalcohol and benzylalcohol .
  • the enzyme used in this invention is hydrolytic enzyme such as lipase, protease and esterase. They have been used in optical resolution of certain compounds as described in Lana E. Janes, et al . , Chem. Eur. J. , 4:2324-2331(1998) and US 5,928,933.
  • the selection of the enzymes is highly dependent on a structure of compounds. For example, in the Examples described below representing the most preferable embodiments of this invention, it is lipase that shows the most outstanding enantioselectivity and yield to tetra-2- furoic acid butylester among many ⁇ -substituted heterocycliccarboxylic acid esters.
  • ⁇ -substituted heterocycliccarboxylic acid esters can be optically resolved by aminolysis with hydrolytic enzymes such as lipase, protease and esterase. Therefore, it would be appreciated that other lipase, protease or esterase in addition to one described in the following Examples can play a role in optical resolution of other ⁇ -substituted heterocycliccarboxylic acid esters in addition to tetrahydro-2-furoic acid.
  • the enzyme used in optical resolution is lipase.
  • the lipase used in optical resolution exhibits different patterns in a favorable type of enantiomer and compound to be reacted, and reactivity, which is depended largely on its source
  • the lipase is derived from
  • the R-NH 2 useful in aminolysis of this invention includes ammonia., methylamine, ethylamine, prophylamine, isoprophylamine, n-butylamine, isobutylamine, tert- butylamine, diethylamine, dimethylamine, methylethylamine and benzylamine, more preferably n-butylamine, tert- butylamine or ammonia and the most preferably ammonia .
  • the aminolysis described above may be usually performed at 4-70 ° C, more preferably at 10-40 ° C.
  • this step may be performed by adding an organic solvent to the reaction mixture and standing at a low temperature (-80°C to 4 ° C) to deposit ⁇ -substituted heterocycliccarboxylic acid amide; in which the organic solvent (for example, ethers such as diethylether, methylethylether, methyl fcert- butylether, methylisobutylether and petroleum ether) is capable of dissolving ⁇ -substituted heterocycliccarboxylic acid ester and incapable of dissolving ⁇ -substituted heterocycliccarboxylic acid amide.
  • the deposition enables an optically active amide to be crystallized and isolated, and an optically active ester to be remained in an organic solvent layer.
  • optically active ester remained in the organic solvent layer is collected by removing the organic solvent with an evaporator and the like.
  • the optical purity of optically active amide isolated by crystallization may be improved where redissolved in alcohol organic solvents or ether organic solvents and recrystallized.
  • the alcohol organic solvent includes but not limited to ethanol, methanol and propanol
  • the ether organic solvent includes but not limited to diethylether, methylethylether, methyl tert-butylether, methylisobutylether and petroleum ether.
  • optically active ester and amide are further treated to convert into optically active carboxylic acid.
  • the cleavage of ester bond may be carried out by any methods known in the art; for example, for acidic hydrolysis, inorganic acid such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid and the like may be used, and for alkaline hydrolysis, inorganic alkali such as sodium hydroxide, potassium hydroxide, barium hydroxide, calcium hydroxide and the like may be used.
  • inorganic acid such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid and the like
  • alkaline hydrolysis inorganic alkali such as sodium hydroxide, potassium hydroxide, barium hydroxide, calcium hydroxide and the like may be used.
  • the ⁇ -substituted heterocycliccarboxylic acid ester is tetrahydro-2-furoic acid ester
  • the ⁇ - substituted heterocycliccarboxylic acid amide is tetrahydro-2-furoic acid amide
  • the ⁇ -substituted heterocycliccarboxylic acid is tetrahydro-2-furoic acid.
  • a method for preparing an optically active R- tetrahydro-2-furoic acid and/or S-tetrahydro-2-furoic acid which comprises the steps of: (a) dissolving a racemic compound of tetrahydro-2-furoic acid ester in an alcohol organic solvent; (b) adding lipase derived from Candida antarctica and ammonia to the solution containing the racemic compound; (c) isolating the optically active compounds of the formula II, the formula III and the formula IV from the reaction mixture; and (d) hydrolyzing the isolated optically active compound with acid or alkali.
  • the present invention provides a method for preparing an optically active ⁇ -substituted heterocycliccarboxylic acid ester and/or an optically active ⁇ -substituted heterocycliccarboxylic acid amide.
  • this invention provides a method for an optically active ⁇ - substituted heterocycliccarboxylic acid.
  • this invention provides an optically active .R-tetrahydro-2- furoic acid and/or S-tetrahydro-2-furoic acid.
  • the methods of this invention can avoid the necessity for the expensive optical resolution agents, simplify the processes, obtain R- and S- enantiomers simultaneously and increase highly the optical purity and yield.
  • Reaction was performed in the same manner as Example I, except that 10% (w/v) of racemic tetra-2-furoic acid species and other forms of substrates such as tetrahydro-2-furoic acid benzyl ester, tetrahydro-2-furoic acid butyl ester and tetrahydro-2-furoic acid ethyl ester were employed. The resultants then were analyzed.
  • This example shows the method for optical resolution of racemic THFA ester in organic solvent into optically active THFA ester and THFA amide by reacting with the enzyme under the presence of amine compound.
  • the enzyme was filtered through Whattman Filter No.5, 50 ml of ether was mixed into filtrate, allowed to stand overnight at -20 ° C and crystals formed thus were collected by filtering on Whattman Filter No.5. Consecutively, 1.1 g of the crystal was dissolved in 10 ml of heated ethanol, THFA amide crystal after 1 day crystallization at -20 ° C was gained and dried, 0.8 g of the final THFA amide was acquired and the optical purity of that was measured by the chiral chromatography in Example I. The result indicated 99.8%ee of optical purity.
  • THFA butyl ester THFA ethyl ester
  • THFA ethyl ester was produced by transesterification in which the ester bond of the non-reactive isomer was attacked by CH 3 CH 2 0 " of ethanol and catalyzed by lipase; in which the non-reactive isomer among the substrate, racemic THFA butyl ester, is one not reacted with lipase in aminolysis. Consequently, the THFA ethyl ester was produced by simultaneous reactions of transesterification and aminolysis. It is impossible for such transesterification to occur in the absence of lipase.
  • Example VII Optical Resolution by Simultaneous Reactions of Transesterification and Aminolysis This Example shows the method for optical resolution with high yield of optically active THFA ester and THFA amide by dissolving racemic THFA ester into ethanol and reacting with enzyme in the presence of amine compound, thereby permitting simultaneous reactions of transesterification and aminolysis.
  • Example VIII Conversion of R-Tetrahydro-2-Furoic Acid Ester into R-Tetrahydro-2-Furoic Acid This Example shows the method for the production of optically active THFA by hydrolyzing the optically active THFA ester of Example VII with acid or alkali.
  • This Example shows the method for the production of optically active THFA by hydrolyzing the optically active THFA amide of Example VII with acid or alkali.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invetion relates to a method for preparing an optically active compound from a racemic α-substituted heterocycliccarboxylic acid ester, more particularly, relates to method for preparing an optically active α-substituted heterocycliccarboxylic acid ester of the formula II and/or an optically active α-substituted heterocycliccarboxylic acid amide of the formula III, which comprises the steps of: (a) dissolving in an organic solvent a racemic compound of α-substituted heterocycliccaboxylic acid ester represented by the formula I; (b) adding an enzyme selected from the group consisting of lipase, protease and esterase, and R-NH2 to a solution containing the racemic compound; and (c) isolating the optically active compounds of the formula II and the formula III from the reaction mixture.

Description

METHOD FOR PREPARING OPTICALLY ACTIVE α -SUBSTITUTED HETEROCYCLICCARBOXYLIC ACID ESTER
BACKGROUND OF THE INVENTION FIELD OF THE INVENTION
The present invention relates to a method for preparing an optically active compound, more particularly, relates to a method for preparing an optically active compound from an racemic α-substituted heterocycliccarboxylic acid ester.
DESCRIPTION OF THE RELATED ART
Optically active tetrahydro-2-furoic acid (THFA), a representative compound of optically active α-substituted heterocycliccarboxyic acids has a wide variety of uses as a chiral building block. For example, R- (+) -tetrahydro-2- furoic acid is useful as a side chain intermediate of penem antibiotics, and S- (-) -tetrahydro-2-furoic acid is useful as a chiral intermediate of organic synthesis. In order to prepare optically active THFA from racemic THFA, an optical resolution must be performed. The optical resolution of racemates has been performed first by Belanger in 1983 { Can . J. Chem. 61:1383(1983)). However, the method had economic demerits using expensive brucine and ephedrine as resolving agents. Also, JP Publication No. 1989-216983 discloses a method for optical resolution of R, S-tetrahydro-2-furoic acid conversed into a diastereomer salt using l-(4- phenylhalide) ethylamine as a resolving agent. However, the method also has problems such as high expense of optically active amines, very low concentration of R, S-tetrahydro-2- furoic acid and low purity and yield of products. In addition, for resolving racemates, (a) hydrolysis in aqueous solution using enzymes such as esterase, lipase and protease and (b) transesterification have been proposed. In recent years, studies of optical resolution by enzymatic non-aqueous aminolysis have been intensively made. For example, Gotor, V. et al . have succeeded in conversing racemic 2-chloropropionate ethyl ester into 40- 95%ee (S) -2-chloropropionate amide by optical resolution using Candida cylindracea lipase { Tetrahedron Lett . 29:6973-697491988)). Gotor, V. et al . also have reported that reacting racemic 2-methylbutylrate ethyl ester with Candida cylindracea lipase (CCL) and Pseudomonas cepacia lipase (PCL) could produce chiral amide ( Tetrahedron Lett . 47 :9207-9214 (1991) ) . In addition, Gotor, V. et al . have proposed that S-hydroxybutylate amide could be prepared in high purity by reacting racemic 3-hydroxybutylate ethyl ester with Candida antarctica lipase (CAL) { Tetrahedron : Asymmetry 3:1519-1522 (1992) ) .
Optical resolution process of racemic amino ester with enzymatic aminolysis has been known in the art. Sheldon, R. A. et al . have optically resolved D, L-phenylglycine methyl ester into .R-phenylglycine amide and S-phenylglycine ester with Candida antarctica lipase (CAL) in t-butanol {J. Molec . Catal . B:Enzym. 5:155-157(1998)).
Optical resolutions of racemic amine have been reported, for example, Reetz, M. T. et al . have resolved racemic 2- phenylethylamine using Candida antarctica lipase (CAL) in purity of 99%ee by acylation of .R-isomeric amine ( Chimia . 48:570(1994)). This method has been known to be applicable to optical resolutions of other amines .
Chiou, T. . et al . have reported an optical resolution method of amino alcohol such as propranol using Candida cylindracea lipase (CCL) through N-acylation (Bioorg-. Med. Chem. Lett . 7:433-436(1997)).
As described previously, the racemic compounds that may be optically resolved into chiral compounds by aminolysis using lipase include a wide variety of compounds.
Meanwhile, Wong, C. H. et al . have reported the results of optical resolution in which 1- (1-naphthyl) ethylamine and racemic alcohol as racemic amine are reacted with diallylyl carbonate and subtilisin, respectively { Tetrahedron Lett . 37:6287-6290(1996)), which represents one example of aminolysis by protease, a kind of hydrolytic enzyme.
However, although many researches as described previously have been made, no research for optical resolution of α-substituted heterocycliccarboxylic acid ester by enzymatic aminolysis has been reported yet, which may be ascribed to significantly slow reaction rates depending on ester types and frequent non-occurrence of enantioselectivity.
Throughout this application, various patents and publications are referenced and citations are provided in parentheses. The disclosure of these patents and publications in their entities are hereby incorporated by references into this application in order to more fully describe this invention and the state of the art to which this invention pertains.
SUMMARY OF THE INVENTION
It is an object of this invention to provide a method for preparing an optically active α-substituted heterocycliccarboxylic acid ester and/or an optically active α-substituted heterocycliccarboxylic acid amide.
It is another object of this invention to provide a method for preparing an optically active α-substituted heterocycliccarboxylic acid. It is still another object of this invention to provide a method for preparing an optically active .R-tertrahydro-2- furoic acid and/or S-tetrahydro-2-furoic acid.
DETAILED DESCRIPTION OF THE INVENTION In one aspect of this invention, there is provided a method for preparing an optically active α-substituted heterocycliccarboxylic acid ester of the formula II and/or an optically active α-substituted heterocycliccarboxylic acid amide of the formula III, which comprises the steps of: (a) dissolving in an organic solvent a racemic compound of α-substituted heterocycliccarboxylic acid ester represented by the formula I; (b) adding an enzyme selected from the group consisting of lipase, protease and esterase, and R-NH2 to a solution containing the racemic compound; and (c) isolating the optically active compounds of the formula II and the formula III from the reaction mixture;
Figure imgf000006_0001
(ID
Figure imgf000006_0002
CONHR
( I I I ) wherein Rx is non-substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl ; R is H or non-substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl; X is 0, S or N; and n is an integer of 1-5.
The principle reaction mechanism of this invention is summarized by the Scheme I :
Figure imgf000007_0001
( I )
According the method of this invention, the compound with R or S configuration among racemic α-substituted heterocycliccarboxylic acid ester as starting material, is resolved through aminolysis by an enzyme that interacts only a specific enantiomer and R-NH2 to form an amide compound, whereas non-reacted compound remains as ester compound. An enantiomer is resolved by the enantiomer- specific reaction. The reaction of this invention is defined as aminolysis used herein, including ammonolysis as well as usual meaning of aminolysis. As described hereinafter, although ammonolysis- occurs when ammonia is used as R-NH2, it is also considered to occurrence of aminolysis herein.
In this invention, the racemic compound of α-substituted heterocycliccarboxylic acid ester by the formula I, an starting material, may be prepared from α-substituted heterocycliccarboxylic acid by the conventional methods known in the art, preferably by reacting with alcohols. The terms used herein "racemic compound" , "racemate" and "racemic mixture" have the same meaning, and each means a mixture of enantiomers deficient in optical activity in which each enantiomer is mixed substantially at a ratio of 50:50.
The racemic α-substituted heterocycliccarboxylic acid may be dissolved in a variety of organic solvents, which include but not limited to oxane, ester, ether, alcohol solvents and mixtures thereof, more preferably is oxane, alcohol organic solvents or combination thereof.
The preferred oxane organic solvent of this invention includes 1,4-dioxane or 1, 3 , 5-trioxane .
According to a preferred embodiment of this invention, the ester organic solvent includes ethylacetate, ethylpropionate, ethylbutyrate, butylbutyrate and butylacetate.
The preferred ether organic solvent includes diethylether, methylethylether, methyl tert-butylether, methylisobutylether and petroleum ether.
According to the most preferable embodiment of this invention, the organic solvent is alcohol. In addition, where an alcohol organic solvent is used, a different reaction from one represented by the Scheme I is produced. That is, transesterification as well as aminolysis occurs simultaneously. Therefore, in another aspect of this invention, there is provided a method for preparing an optically active α- substituted heterocycliccarboxylic acid ester of the formula II, an optically active α-substituted heterocycliccarboxylic acid ester of the formula IV and/or an optically active α-substituted heterocycliccarboxylic acid amide of the formula III, which comprises the steps of: (a) dissolving in an alcoholic organic solvent of R2-0H a racemic compound of the α-substituted heterocycliccarboxylic acid ester of the formula I; (b) adding an enzyme selected from the group consisting of lipase, protease and esterase, and R-NH2 to a solution containing the racemic compound; and (c) isolating the optically active compounds of the formula II and the formula IV from the reaction mixture;
Figure imgf000009_0001
(i)
Figure imgf000009_0002
(ID
Figure imgf000009_0003
CONHR
(HI)
(IV) wherein Rx and R2 is independently non-substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl; R is H or non-' substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl; X is O, S or N; and n is an integer of 1-5.
In case that alcohol organic solvent is used, one enantiomer is subject to aminolysis by enzymes and R-NH2 and R2-0" acts on non-reacted another enantiomer to form a new ester compound (formula IV) .
Where racemic α-substituted heterocycliccarboxylic acid ester is optically resolve by aminolysis in an organic solvent, if the reaction time is too long, the yield of optically active α-substituted heterocycliccarboxylic acid ester may be reduced due to overreaction. In this case, if alcohol organic solvent is used to produce transesterification and aminolysis simultaneously, the optical purity and the yield of final products can be improved and reaction time can be reduced as well.
The final products include 2 types of optically active α-substituted heterocycliccarboxylic acid esters and a α- substituted heterocycliccarboxylic acid amide having an opposite optical activity.
Though many researches have reported that transesterification or aminolysis was attempted for optical resolution of a racemic compound (e.g., Enzyme . Microb . Technol . , 15:367-382(1993)), it has not been reported that the two reactions may be proceeded simultaneously in one reactor as the present invention.
According to a preferred embodiment of this invention, Ri and R2 is independently non-substituted or substituted Cι-C6 alkyl, Cι-C6 alkenyl, Cι-Ce alkynyl, C3-C6 cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl; R is H or non- substituted or substituted Cι-C6 alkyl, Cι-C6 alkenyl, Cι-C6 alkynyl, C3-C6 cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl; X is 0; and n is an integer of 1-3.
The alcohol organic solvent useful in this invention preferably includes but not limited to methanol, ethanol, isopropanol, n-propanol, n-butanol, isobutanol, tert- butanol, isoamylalcohol and benzylalcohol .
The enzyme used in this invention is hydrolytic enzyme such as lipase, protease and esterase. They have been used in optical resolution of certain compounds as described in Lana E. Janes, et al . , Chem. Eur. J. , 4:2324-2331(1998) and US 5,928,933. The selection of the enzymes is highly dependent on a structure of compounds. For example, in the Examples described below representing the most preferable embodiments of this invention, it is lipase that shows the most outstanding enantioselectivity and yield to tetra-2- furoic acid butylester among many α-substituted heterocycliccarboxylic acid esters.
As a result, the subject matter of this invention is that α-substituted heterocycliccarboxylic acid esters can be optically resolved by aminolysis with hydrolytic enzymes such as lipase, protease and esterase. Therefore, it would be appreciated that other lipase, protease or esterase in addition to one described in the following Examples can play a role in optical resolution of other α-substituted heterocycliccarboxylic acid esters in addition to tetrahydro-2-furoic acid.
According to a preferred embodiment of this invention, the enzyme used in optical resolution is lipase. The lipase used in optical resolution exhibits different patterns in a favorable type of enantiomer and compound to be reacted, and reactivity, which is depended largely on its source
(Lana E. Janes, et al . Chem. Eur. J. , 4:2324-2331(1998) and
US 5,928,933). Therefore, according to more preferable embodiment of this invention, the lipase is derived from
Candida cylindracea, Pseudomonas sp. Candida rugosa or Candida antarctica and the most preferable is derived from Candida Antarctica . The R-NH2 useful in aminolysis of this invention includes ammonia., methylamine, ethylamine, prophylamine, isoprophylamine, n-butylamine, isobutylamine, tert- butylamine, diethylamine, dimethylamine, methylethylamine and benzylamine, more preferably n-butylamine, tert- butylamine or ammonia and the most preferably ammonia .
The aminolysis described above may be usually performed at 4-70°C, more preferably at 10-40°C.
If the aminolysis is completed at a time of achieving a desirable optical purity, there remain α-substituted heterocycliccarboxylic acid amide formed by enzyme reaction and its enantiomer, non-reacted α-substituted heterocycliccarboxylic acid ester. The isolation of optically active ester and amide may be carried out by various methods known in the art. For example, this step may be performed by adding an organic solvent to the reaction mixture and standing at a low temperature (-80°C to 4°C) to deposit α-substituted heterocycliccarboxylic acid amide; in which the organic solvent (for example, ethers such as diethylether, methylethylether, methyl fcert- butylether, methylisobutylether and petroleum ether) is capable of dissolving α-substituted heterocycliccarboxylic acid ester and incapable of dissolving α-substituted heterocycliccarboxylic acid amide. The deposition enables an optically active amide to be crystallized and isolated, and an optically active ester to be remained in an organic solvent layer.
The optically active ester remained in the organic solvent layer is collected by removing the organic solvent with an evaporator and the like. The optical purity of optically active amide isolated by crystallization may be improved where redissolved in alcohol organic solvents or ether organic solvents and recrystallized. The alcohol organic solvent includes but not limited to ethanol, methanol and propanol , and the ether organic solvent includes but not limited to diethylether, methylethylether, methyl tert-butylether, methylisobutylether and petroleum ether.
The optically active ester and amide are further treated to convert into optically active carboxylic acid.
Therefore, in still another aspect of this invention, there is provided a method for preparing a J?-α-substituted heterocycliccarboxylic acid of the formula V and/or a S-α- substituted heterocycliccarboxylic acid of the formula VI through an acid or alkali hydrolysis of the α-substituted heterocycliccarboxylic acid ester and/or the α-substituted heterocycliccarboxylic acid amide prepared by the present method described above :
Figure imgf000015_0001
(v)
Figure imgf000015_0002
(VI) wherein X is 0, S or N; and n is an integer of 1-5.
The cleavage of ester bond may be carried out by any methods known in the art; for example, for acidic hydrolysis, inorganic acid such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid and the like may be used, and for alkaline hydrolysis, inorganic alkali such as sodium hydroxide, potassium hydroxide, barium hydroxide, calcium hydroxide and the like may be used.
According to the most preferable embodiment of the present invention, the α-substituted heterocycliccarboxylic acid ester is tetrahydro-2-furoic acid ester, the α- substituted heterocycliccarboxylic acid amide is tetrahydro-2-furoic acid amide and the α-substituted heterocycliccarboxylic acid is tetrahydro-2-furoic acid.
Therefore, in further aspect of this invention, there is provided a method for preparing an optically active R- tetrahydro-2-furoic acid and/or S-tetrahydro-2-furoic acid, which comprises the steps of: (a) dissolving a racemic compound of tetrahydro-2-furoic acid ester in an alcohol organic solvent; (b) adding lipase derived from Candida antarctica and ammonia to the solution containing the racemic compound; (c) isolating the optically active compounds of the formula II, the formula III and the formula IV from the reaction mixture; and (d) hydrolyzing the isolated optically active compound with acid or alkali.
It has been known that the conventional methods for optical resolution are uneconomic because of using chiral amines to form diastereomers and using a large amount of organic solvents. In this regard, it is surprising that the method of this invention can avoid the necessity for the expensive optical resolution agents, simplify the processes, obtain R- and S- enantiomers simultaneously and increase highly the optical purity and yield.
The present invention provides a method for preparing an optically active α-substituted heterocycliccarboxylic acid ester and/or an optically active α-substituted heterocycliccarboxylic acid amide. In addition, this invention provides a method for an optically active α- substituted heterocycliccarboxylic acid. Further to this, this invention provides an optically active .R-tetrahydro-2- furoic acid and/or S-tetrahydro-2-furoic acid. The methods of this invention can avoid the necessity for the expensive optical resolution agents, simplify the processes, obtain R- and S- enantiomers simultaneously and increase highly the optical purity and yield.
The following specific examples are intended to be illustrative of the invention and should not be construed as limiting the scope of the invention as defined by appended claims .
EXAMPLES
Example I: Screening of Enzymes Showing Specificity for Tetrahydro-2-Furoic Acid (THFA) Ester
2% (w/v) of racemic tetrahydro-2-furoic acid butyl ester (Aldrich, USA) and 0.1% (w/v) of each enzyme indicated in Table I (Sigma, USA; Roche, USA; and Amano Enzyme, USA) were added to 500 μl of reaction solvent (0.5 M ammonia in 1,4-dioxane) and reacted for 20 hr at 30°C. 100 μl of the reacted solution was dissolved in 1 m# of ethanol and analyzed using gas chromatography and chiral gas chromatography (Table I) . Gas chromatography was performed with HP-5 column (Hewlett-Packard, USA) at initial temperature of 80 °C and final temperature of 200 °C. The chiral gas chromatography was performed with β -dextrin column (Chrompack, USA) at initial temperature of 110 °C and final temperature of 200°C. Table I
Strain Optical Enantiomer of purity (%ee) remained ester
Ester Amide
Protease Bacillus subtilis 2.0 0.0 Aspergillus oryzae 0.0 0.0 Aspergillus saitol 2.3 0.0 Rhizopus sp. 0.0 0.0 Bacillus 2.7 3.0 1 i cheni formi s Bacillus 0.0 0.0 amyloliguefaciens
Lipase Candida cylindracea 30.0 2.3 S Pseudomonas sp . 1.0 0.0 Porcine pancreatic Candida Antarctica 99.6 85 R Candida rugosa 20.1 0.0 R Rhizomucor miehei
Estease Porcine liver
As shown in Table I, the reaction employing lipase from Candida antarctica gave the highest optical purity (99.6%ee) and the highest yield of remained tetrahydro-2- furoic acid butyl ester. Therefore, the following experiments were performed with the lipase from Candida antarctica.
Example II: Specificity for Other Tetrahydro-2-Furoic
Acid (THFA) Ester
Reaction was performed in the same manner as Example I, except that 10% (w/v) of racemic tetra-2-furoic acid species and other forms of substrates such as tetrahydro-2-furoic acid benzyl ester, tetrahydro-2-furoic acid butyl ester and tetrahydro-2-furoic acid ethyl ester were employed. The resultants then were analyzed.
99.6%ee optical purity of tetrahydro-2-furoic acid ester was achieved in 26 hr for THFA benzyl ester, 21 hr for THFA butyl ester and 36 hr for THFA ethyl ester. These results indicate that THFA butyl ester is the most preferred substrate due to the fastest optical resolution; thus tetrahydro-2-furoic acid benzyl ester was used as a substrate in the following experiments.
Example III: Optical Resolution of Tetrahydro-2-Furoic
Acid (THFA) Ester
This example shows the method for optical resolution of racemic THFA ester in organic solvent into optically active THFA ester and THFA amide by reacting with the enzyme under the presence of amine compound.
2.5 g of THFA butyl ester and 0.4 g of lipase from Candida antarctica were added in 25 m£ of reaction solvent (0.5 M of ammonia in 1,4-dioxane) and the mixture was reacted at 20 °C with agitation. Small portions of reaction mixture were sampled at constant interval, analyzed by chiral chromatography in Example I, revealing that the optical purity of ester compound was 99%ee at 28 hr and that of amide compound was 88%ee.
After the reaction was completed, the enzyme was filtered through Whattman Filter No.5, 50 ml of ether was mixed into filtrate, allowed to stand overnight at -20 °C and crystals formed thus were collected by filtering on Whattman Filter No.5. Consecutively, 1.1 g of the crystal was dissolved in 10 ml of heated ethanol, THFA amide crystal after 1 day crystallization at -20 °C was gained and dried, 0.8 g of the final THFA amide was acquired and the optical purity of that was measured by the chiral chromatography in Example I. The result indicated 99.8%ee of optical purity. Furthermore, 72 ml of the filtrate after precipitation by ether described above was evaporated by rotary evaporator (Buehi, Germany) to dry organic solvent yielding 0.9 g of final THFA butyl ester (corresponding to 72% of theoretical yield) . Analysis using chiral chromatography in Example I showed 99.8%ee of optical purity.
Example IV: Optical Resolution Depending on Type of
Amines
10% (w/v) of racemic THFA butyl ester and 0.1% (w/v) of Candida antarctica lipase were added into 1 ml of 1,4- dioxane reaction solvent, amine compound (n-butyl amine, benzyl amine or tert-butyl amine) in an amount of 1.1 times
(w/v) of the THFA butyl ester was added and the mixture was reacted for 11 hr at 30°C. Thereafter, 100 μi of the reacted mixture was dissolved in 1 ml of ethanol and optical purity was measured by the gas chromatography and . chiral chromatography employed in Example I (Table II)
Table II
Amine compound Optical Purity (%ee) Enantiomer of remained ester
Ester Amine n-butyl amine 23.1 1.3 R tert-butyl amine 2.8 1.0 R
Benzyl amine 39.2 7.4 R
As shown in Table II, the reactions occurred rapidly using benzyl amine and 23-butyl amine but the reaction hardly occurred employing tert-butyl amine. The optical purities of the remained ester and produced amine were inferior to those of Example I employing ammonia.
Example V: Optical Resolution Depending on Organic
Solvents
10% (w/v) racemic THFA butyl ester and 1% (w/v) Candida antarctica lipase was added into 1 ml of each reaction solvents indicated in Table III containing 0.5 M ammonia and the mixtures were allowed to react for 24 hr at 25°C. Thereafter, optical purity was measured by chiral chromatography used in Example I (Table III) . Table III
Organic Solvents Optical Purity Enantiomer of (%ee) remained ester
Ester Amide
1, 4-dioxane 59.5 22 .6 R
1, 4-dioxane : ethanol 100 83, .1 R
(50:50)
Ethanol 99.8 79, .5 R
As shown in Table III, the mixture of ethanol and 1,4- dioxane showed the highest optical purity and ethanol solvent showed higher optical purity than 1,4-dioxane.
Example VI: Simultaneous Occurrence of Transesterification and Aminolysis
In an effort to verify the effect of solvents of various compositions of 1,4-dioxane and ethanol on optical purity, experiment was done as follows:
10% (w/v) racemic THFA butyl ester and 1% (w/v) Candida antarctica lipase were added into 1 ml of the reaction solvents in Table IV containing 0.5 M ammonia, and the mixture was reacted for 19 hr at 25°C . Thereafter, optical purity was measured by chiral gas chromoatography used in Example I (Table IV) . Table IV
Organic Solvent Optical Purity Enantiomer of (%ee) remained ester
Ester Amide
1, 4-dioxane -.ethanol 81.5 100 R
(2.3:1) 1,4-dioxane: ethanol 85.1 90.2 R
(1.5:1) 1, 4-dioxane: ethanol 91.5 89.8 R
(0.6:1) 1, 4-dioxane .-ethanol 96.1 85.2 R
(0.3:1)
Ethanol 99.1 76.1 R
After reaction, there remained 3 compound species, i.e. THFA butyl ester, THFA ethyl ester and THFA amide. Among them, THFA ethyl ester was produced by transesterification in which the ester bond of the non-reactive isomer was attacked by CH3CH20" of ethanol and catalyzed by lipase; in which the non-reactive isomer among the substrate, racemic THFA butyl ester, is one not reacted with lipase in aminolysis. Consequently, the THFA ethyl ester was produced by simultaneous reactions of transesterification and aminolysis. It is impossible for such transesterification to occur in the absence of lipase.
In addition, ethanol alone showed higher optical purity and yield of produced THFA ethyl ester and remained THFA butyl ester than that of mixture with 1,4-dioxane.
Example VII: Optical Resolution by Simultaneous Reactions of Transesterification and Aminolysis This Example shows the method for optical resolution with high yield of optically active THFA ester and THFA amide by dissolving racemic THFA ester into ethanol and reacting with enzyme in the presence of amine compound, thereby permitting simultaneous reactions of transesterification and aminolysis.
21 g of THFA butyl ester and 0.9 g of Candida antarctica lipase were added into 30 ml of reaction solvent
(2 M ammonia in ethanol) , the mixture was reacted at 20°C under stirring, and ammonia gas was injected into at regular time interval . The mixture was sampled at regular time interval to apply on the chiral gas chromatography employed in Example I, and the results showed 99.5%ee of optical purity of THFA butyl ester and THFA ethyl ester and 77.5%ee of optical purity of THFA amide at 11 hr. After reaction, the enzyme was discarded by Whattman Filter No.5 and ethanol was dried under vacuum by rotary evaporator resulting in 14 g of product. Thereinafter, 2 volumes of ether was added, precipitated for 6 hr at -20°C and crystal was gained on Whattman Filter No .5. 11 g of the crystal was dissolved in 50 ml of heated ethanol and allowed to stand overnight at -20°C to from recrystallized THFA amide. The recrystallized THFA amide was dried and its optical purity was measured using the chiral gas chromatography in Example I. The analysis showed 99.8%ee of optical purity. Furthermore, 42 ml of the filtrate after precipitation by ether described above was evaporated by rotary evaporator (Buehi, Germany) to dry organic solvent producing 9 g of optically active THFA butyl ester and THFA ethyl ester (90% of theoretical yield), and 99.8%ee of optical purity was analyzed by the chiral gas chromatography used in Example I . Table V shows the yield of THFA ester compared to that of Example III performing aminolysis with only 1,3-dioxane as organic solvent .
Table V
Yield of THFA Reaction time ester (%) (hr)
Example III 36% 28
Example VII 45% 11
As shown in Table V, although good yield (corresponding to 72% of theoretical yield) was acquired by sole aminolysis as Example III, the enhanced yield and shortened reaction time were gained by simultaneous reactions of transesterification and aminolysis employing different alcohols from that contained in the THFA ester solution as organic solvent (in this Example, substrate was THFA butyl ester and organic solvent was ethanol) .
Example VIII: Conversion of R-Tetrahydro-2-Furoic Acid Ester into R-Tetrahydro-2-Furoic Acid This Example shows the method for the production of optically active THFA by hydrolyzing the optically active THFA ester of Example VII with acid or alkali.
12.5 % (w/v) of R-THFA ester (98.7%ee) was added into 5 ml of I N HCl or 1 N NaOH and hydrolysis was performed for 3 hr at 60°C . And then, non-reacted substrate was extracted by addition of 5 ml of ethyl acetate, aqueous layer was acidified to pH 2 with HCl solution, and 0.46 g of .R-THFA was extracted by addition of 10 ml of ethyl acetate. Furthermore, in an effort to measure the optical purity of the final .R-THFA, 5 mg of .R-THFA was converted into butyl ester species by adding 0.2 ml of butanol. Analysis using chiral gas chromatography in Example I indicated the optical purity was constantly maintained. The data are summarized in Table VI.
Table VI
Condition for Hydrolysis Optical Purity (%ee)
Used substrate 98.7 1 N NaOH 98.0 1 N HCl 98.0 Example IX: Conversion of S-Tetrahydro-2-Furoic Acid Amide into S-Tetrahydro-2-Furoic Acid
This Example shows the method for the production of optically active THFA by hydrolyzing the optically active THFA amide of Example VII with acid or alkali.
12.5 % (w/v) of S-THFA amide (99%ee) was added into 5 ml of 1 N HCl or 1 N NaOH and hydrolysis was performed for 3 hr at 60°C. And then, non-reacted substrate was extracted by addition of 5 ml of ethyl acetate, aqueous layer was acidified to pH 2 with HCl solution, and 0.6 g of S-THFA was extracted by addition of 10 ml of ethyl acetate. Furthermore, in an effort to measure the optical purity of the final S-THFA, 5 mg of R-THFA was converted into butyl ester species by adding 0.2 ml of butanol. Anaylsis using the chiral gas chromatography in Example I indicated the optical purity was constantly maintained. The data are summarized in Table VII.
Table VII
Condition for Hydrolysis Optical Purity (lee)
Used Substrate 99.0
IN NaOH 98.4
IN HCl 98.2

Claims

What is claimed is:
1. A method for preparing an optically active α- substituted heterocycliccarboxylic acid ester of the formula II and/or an optically active α-substituted heterocycliccarboxylic acid amide of the formula III, which comprises the steps of:
(a) dissolving in an organic solvent a racemic compound of α-substituted heterocycliccarboxylic acid ester represented by the formula I ;
(b) adding an enzyme selected from the group consisting of lipase, protease and esterase, and R-NH2 to a solution containing the racemic compound; and
(c) isolating the optically active compounds of the formula II and the formula III from the reaction mixture ;
Figure imgf000028_0001
(I)
Figure imgf000028_0002
(III) wherein Ri is non-substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl; R is H or non-substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl; X is 0, S or N; and n is an integer of 1-5.
2. A method for preparing an optically active α- substituted heterocycliccarboxylic acid ester of the formula II, an optically active α-substituted heterocycliccarboxylic acid ester of the formula IV and/or an optically active α-substituted heterocycliccarboxylic acid amide of the formula III, which comprises the steps of: (a) dissolving in an alcoholic organic solvent of R2-0H a racemic compound of the α-substituted heterocycliccarboxylic acid ester of the formula I;
(b) adding an enzyme selected from the group consisting of lipase, protease and esterase, and R-NH2 to a solution containing the racemic compound; and
(c) isolating the optically active compounds of the formula II and the formula IV from the reaction mixture ,-
Figure imgf000030_0001
(ID
CONHR
Figure imgf000030_0002
Figure imgf000030_0003
(iv) wherein Ri and R2 is independently non-substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl; R is H or non- substituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl; X is O, S or N; and n is an integer of 1-5.
3. A method for preparing a R-α-substituted heterocycliccarboxylic acid of the formula V and/or a S-α- substituted heterocycliccarboxylic acid of the formula VI through an acid or alkali hydrolysis of the α-substituted heterocycliccarboxylic acid ester and/or the α-substituted heterocycliccarboxylic acid amide prepared by the method of claim 1 or 2;
Figure imgf000031_0001
(v)
(C
Figure imgf000031_0002
(VI) wherein X is O, S or N; and n is an integer of 1-5.
4. The method according to any one of claims 1 to 3, wherein Ri and R2 is independently non-substituted or substituted Cι-C6 alkyl, Cι-C6 alkenyl, Cχ-Cβ alkynyl, C3-C6 cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl; R is H or non-substituted or substituted Cι~C6 alkyl, Cι-C6 alkenyl, Cx-C6 alkynyl, C3-C6 cycloalkyl, aryl, arylalkyl, heteroarylalkyl or alkaryl; X is 0; and n is an integer of 1-3.
5. The method according to any one of claims 1 to 3 , wherein the racemic compound of α-substituted heterocycliccarboxylic acid ester of the formula I is prepared by reacting a racemic α-substituted heterocycliccarboxylic acid with an alcohol.
6. The method according to any one of claims 1 to 3, wherein the organic solvent is selected from the group consisting of oxane, ester, ether, alcohol solvents and combinations thereof.
7. The method according to claim 6, wherein the oxane organic solvent is 1,4-dioxane or 1, 3 , 5-trioxane .
8. The method according to claim 6, wherein the ester organic solvent is selected from the group consisting of ethylacetate, ethylpropionate, ethylbutyrate, butylbutyrate and butylacetate.
9. The method according to claim 6, wherein the ether organic solvent is selected from the group consisting of diethylether, methylethylether, methyl tert-butylether, methylisobutylether and petroleum ether.
10. The method according to claim 6, wherein the alcohol organic solvent is selected from the group consisting of methanol, ethanol, isopropanol, π-propanol, π-butanol, isobutanol, tert-butanol, isoamylalcohol and benzylalcohol .
11. The method according to any one of claims 1 to 3 , wherein the enzyme is lipase.
12. The method according to claim 11, wherein the lipase is derived from Candida antarctica .
13. The method according to any one of claims 1 to 3 , wherein R-NH2 is selected from the group consisting of ammonia, methylamine, ethylamine, prophylamine, isoprophylamine, n-butylamine, isobutylamine, tert- butylamine, diethylamine, dimethylamine, methylethylamine and benzylamine .
14. The method according to claim 3, wherein the acid used in hydrolysis is selected from the group consisting of hydrochloric acid, sulfuric acid, nitric acid and phosphoric acid.
15. The method according to claim 3, wherein the alkali used in hydrolysis is selected from the group consisting of sodium hydroxide, potassium hydroxide, barium hydroxide and calcium hydroxide.
16. The method according to any one of claims 1 to 3, wherein the α-substituted heterocycliccarboxylic acid ester is tetrahydro-2-furoic acid ester, the α-substituted heterocycliccarboxylic acid amide is tetrahydro-2-furoic acid amide and the α-substituted heterocycliccarboxylic acid is tetrahydro-2-furoic acid.
17. The method according to any one of claims 1 to 3 , wherein the step of isolating the optically active compound is performed by adding an organic solvent to the reaction mixture and standing at a low temperature to deposit α- substituted heterocycliccarboxylic acid amide; in which the organic solvent is capable of dissolving α-substituted heterocycliccarboxylic acid ester and incapable of dissolving α-substituted heterocycliccarboxylic acid amide.
18. The method according to claim 17, wherein the organic solvent used in the depositing step is ether organic solvent selected from the group consisting of diethylether, methylethylether, methyl tert-butylether, methylisobutylether and petroleum ether.
19. The method according to claim 17, which further comprises dissolving the deposited α-substituted heterocycliccarboxylic acid amide in an alcohol organic solvent or ether organic solvent and recrystallizing.
20. The method according to claim 19, wherein the alcohol organic solvent is selected from the group consisting of ethanol, methanol and propanol, and the ether organic solvent is selected from a group consisting of diethylether, methylethylether, methyl tert-butylether, methylisobutylether and petroleum ether.
21. A method for preparing an optically active R- tetrahydro-2-furoic acid and/or £-tetrahydro-2~furoic acid, which comprises the steps of:
(a) dissolving a racemic compound of tetrahydro-2- furoic acid ester in an alcohol organic solvent;
(b) adding lipase derived from Candida antarctica and ammonia to the solution containing the racemic compound;
(c) isolating the optically active compounds of the formula II, the formula III and the formula IV from the reaction mixture; and
(d) hydrolyzing the isolated optically active compound with acid or alkali.
PCT/KR2002/001488 2001-08-06 2002-08-06 METHOD FOR PREPARING OPTICALLY ACTIVE α-SUBSTITUTED HETEROCYCLICCARBOXYLIC ACID ESTER WO2003014106A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR2001-47232 2001-08-06
KR1020010047232A KR20030012964A (en) 2001-08-06 2001-08-06 Methods for Preparing Optically Active α-Substituted Heterocycliccarboxylic Acid Ester

Publications (1)

Publication Number Publication Date
WO2003014106A1 true WO2003014106A1 (en) 2003-02-20

Family

ID=19712892

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2002/001488 WO2003014106A1 (en) 2001-08-06 2002-08-06 METHOD FOR PREPARING OPTICALLY ACTIVE α-SUBSTITUTED HETEROCYCLICCARBOXYLIC ACID ESTER

Country Status (2)

Country Link
KR (1) KR20030012964A (en)
WO (1) WO2003014106A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6841688B2 (en) * 2001-12-04 2005-01-11 Sk Corporation Method of preparing optically pure (R)- or (S)- tetrahydrofuranyl ketone
US20120142945A1 (en) * 2010-12-02 2012-06-07 Korea Research Institute Of Chemical Technology Recovery method of highly pure lactic acid and alkyl lactate
CN108342422A (en) * 2018-03-02 2018-07-31 北京海美桐医药科技有限公司 The preparation method of N- substituted amido carbonyl ester type compounds and the application of immobilized lipase

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100788281B1 (en) * 2005-05-03 2007-12-27 주식회사 알.에프.텍 handsfree apparatus and working method of the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928933A (en) * 1998-06-26 1999-07-27 E. I. Du Pont De Nemours & Company Process for the enzymatic resolution of N-(alkoxycarbonyl)-4-ketoproline alkyl esters or N-(alkoxycarbonyl)-4-hydroxyproline alkyl esters using Candida antarctica lipase B

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0150592B1 (en) * 1995-01-03 1998-08-17 남창우 Separation method of racemic (r,s)-1,2-phenylethandiol by using enzymes
GB9614856D0 (en) * 1996-07-15 1996-09-04 Chiroscience Ltd New resolution method
EP0892044B1 (en) * 1997-07-18 2004-12-29 Mitsui Chemicals, Inc. Esterase and its use for the production of optically active chroman compounds
KR100378741B1 (en) * 2000-06-01 2003-04-07 에스케이 주식회사 Method for preparing R- or S-form α-substituted heterocyclic carboxyl acid and counter enantiomeric form of α-substituted heterocyclic carboxyl acid ester thereto using enzyme
KR20010109877A (en) * 2000-06-03 2001-12-12 이계안 Ball joint for vehicle

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928933A (en) * 1998-06-26 1999-07-27 E. I. Du Pont De Nemours & Company Process for the enzymatic resolution of N-(alkoxycarbonyl)-4-ketoproline alkyl esters or N-(alkoxycarbonyl)-4-hydroxyproline alkyl esters using Candida antarctica lipase B

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BALDESSARI A., MANGONE C.P.: "One-pot biocatalyzed preparation of substituted amides as intermediates of pharmaceuticals", JOURNAL OF MOLECULAR CATALYSIS B: ENZYMATIC, vol. 11, no. 4-6, 22 January 2001 (2001-01-22), pages 335 - 341, XP027407278 *
CHENEVERT ROBERT, GOUPIL DANIEL, ROSE YANNICK STEPHANE: "Enzymic desymmetrization of meso cis,cis-2,4,6-substituted tetrahydropyrans", TETRAHEDRON: ASYMMETRY, vol. 9, no. 24, 24 December 1998 (1998-12-24), pages 4285 - 4288 *
CONDE S., LOPEZ-SERRANO P., MARTINEZ A.: "Candida antarctica lipase B catalyzed amidation of pyroglutamic acid derivatives. A reaction survey", JOURNAL OF MOLECULAR CATALYSIS B: ENZYMATIC, vol. 7, no. 5-6, 20 December 1999 (1999-12-20), pages 299 - 306 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6841688B2 (en) * 2001-12-04 2005-01-11 Sk Corporation Method of preparing optically pure (R)- or (S)- tetrahydrofuranyl ketone
US20120142945A1 (en) * 2010-12-02 2012-06-07 Korea Research Institute Of Chemical Technology Recovery method of highly pure lactic acid and alkyl lactate
US9012685B2 (en) * 2010-12-02 2015-04-21 Korea Research Institute Of Chemical Technology Recovery method of highly pure lactic acid and alkyl lactate
CN108342422A (en) * 2018-03-02 2018-07-31 北京海美桐医药科技有限公司 The preparation method of N- substituted amido carbonyl ester type compounds and the application of immobilized lipase
CN108342422B (en) * 2018-03-02 2020-08-14 北京海美桐医药科技有限公司 Preparation method of N-substituted amino carbonyl ester compound and application of immobilized lipase

Also Published As

Publication number Publication date
KR20030012964A (en) 2003-02-14

Similar Documents

Publication Publication Date Title
US5728876A (en) Resolution of the racemates of primary and secondary amines by enzyme-catalyzed acylation
US6214608B1 (en) Resolution of racemates of primary and secondary heteroatom-substitued amines by enzyme-catalyzed acylation
NO327575B1 (en) Process for the preparation of optically active (1S, 4R) or (1R, 4S) -1-amino-4- (hydroxymethyl) -2-cyclopentenes or their salts and / or of (1S, 4R) - or (1R, 4S) ) -1-amino-4- (hydroxymethyl) -2-cyclopentene derivatives or their salts
Kámán et al. Enzymatic resolution of alicyclic β-lactams
WO2003014106A1 (en) METHOD FOR PREPARING OPTICALLY ACTIVE α-SUBSTITUTED HETEROCYCLICCARBOXYLIC ACID ESTER
KR20000005286A (en) Enzymatic process for stereoselective preparation of therapeutic amides
KR100378741B1 (en) Method for preparing R- or S-form α-substituted heterocyclic carboxyl acid and counter enantiomeric form of α-substituted heterocyclic carboxyl acid ester thereto using enzyme
US6063615A (en) Enzymatic acylation of amino acid esters using a carboxylic acid ester substituted with oxygen on the alpha carbon
KR100368735B1 (en) Method for preparing R- or S-form α-substituted heterocyclic carboxyl acid using enzyme
KR100395310B1 (en) Method for optically resolving preparing R- or S-form α-substituted heterocyclic carboxyl acid using enzyme
EP1290208B1 (en) Method for optically resolving a racemic alpha-substituted heterocyclic carboxylic acid using enzyme
EP1705252B1 (en) Method for producing optically active N-protected-propargylglycine
KR102547254B1 (en) Method for Preparing 2-hydroxy-r-butyrolactone Using Enzyme
CA2145230A1 (en) Enzymatic resolution of asymmetric alcohols by means of vinyl esters of polybasic carboxylic acids
KR100337387B1 (en) Method for preparing chiral allyl alcohol
EP4036244B1 (en) Enzymatic process for the preparation of (2s)-2-[(4r)-2-oxo-4-propyl-pyrrolidin-1-yl]butyric acid and its conversion into brivaracetam
US5973214A (en) Method for producing an optically active 2-alkanol
EP0239122A2 (en) Process for the enzymatic resolution of racemic 2-amino-1-alkanols
KR19980701914A (en) Method for Separating Heteroatomic Substituted Primary and Secondary Amine Racemates by Enzyme Catalyzed Acylation Reaction
US7662610B2 (en) Synthesis of intermediates for the preparation of pramipexol
JP2006219494A (en) Optically active 3-n substituted aminoisobutyric acids and their salts and production method thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VC VN YU ZA ZM

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP